相关实验视频
Updated: May 7, 2025
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.2K
卡普托普里尔挑战测试预测了初级阿尔多斯特罗尼斯的心脏结构和功能障碍
Uei-Lin Chen1,2,3, Che-Wei Liao4, Shuo-Meng Wang5
1Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
The Journal of clinical endocrinology and metabolism
|January 2, 2025
概括
卡普托普里尔挑战测试 (CCT) 揭示了与原发性阿尔多斯特症 (PA) 中的心脏问题相关的阿尔多斯特水平. 较高的CCT后阿尔多素预测了更糟糕的心脏重塑,但也更大的治疗改善.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 医学诊断 医学诊断 医学诊断
背景情况:
- 卡普托普里尔挑战测试 (CCT) 评估了原发性阿尔多斯 (PA) 中的阿尔多斯的产量.
- 它有助于确定氨酸和血管新生素II独立的阿尔多斯特生产的大小.
- 这有助于识别PA的存在和严重程度.
研究的目的:
- 为了研究CCT后血中阿尔多素度 (PAC) 和心血管改造之间的关联.
- 为了检查CCT后的PAC与腹筋功能障碍之间的联系.
- 评估CCT后PAC对PA患者的预后和治疗影响.
主要方法:
- 540名PA患者的回顾性分析,包括完整的CCT和心声回声数据.
- 在基线和治疗后1年的临床和心声学参数的评估.
- 包括限制立方线和线性回归在内的统计分析.
主要成果:
- 在CCT后的PAC显示出与左心室质量指数 (LVMI) 和E/e'具有显著的线性关联,表明风险的连续性.
- 后CCTPAC与基线LVMI,E/e和左心房体积指数 (LAVI) 相关.
- 较高的CCT后PAC与治疗后LVMI,E/e和LAVI的更大改善相关,与基线阿尔多素水平不同.
结论:
- 较高的CCT后PAC与更严重的左心室重塑和扩张功能障碍有关.
- 后CCTPAC预测了PA患者心脏病的严重程度.
- 增加的CCT后PAC也表明PA向治疗后心脏结构和功能改善的潜力更大.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
299
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
299
01:22Heart Failure Drugs: Diuretics
273
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
273
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
373
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
373